Actinium Pharmaceuticals, Inc. (Delaware) (AMEX:ATNM) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rosemary Mazanet Other companies: Kairos Pharma, Ltd. (Director · Sep 16, 2024 – Sep 16, 2024 · Past); SELLAS Life Sciences Group, Inc. (Chief Medical Officer · Feb 1, 2012 – Jan 29, 2013 · Past); Abeona Therapeutics Inc. (Director · Jan 4, 2007 – Jan 4, 2007 · Past); Aksys Ltd (Director · Aug 9, 2006 – Oct 24, 2006 · Past); Oncternal Therapeutics Inc (Director · Jan 1, 2006 – Jun 20, 2024 · Past) | Director · Dec 28, 2012 – May 15, 2013 · Past |
| Richard I. Steinhart Other companies: BioXcel Therapeutics, Inc. (Senior Vice President and Chief Financial Officer · Since at least Mar 7, 2018); Atossa Therapeutics, Inc. (Director · Since at least Mar 1, 2014); MELA Sciences Inc (Chief Financial Officer · May 14, 2010 – Aug 5, 2013 · Past); TG Therapeutics, Inc. (Director · Mar 25, 2008 – Mar 3, 2010 · Past) | Director · Since at least Nov 8, 2013 |
| Anil Kapur Other companies: Nurix Therapeutics, Inc. (Director · Since at least Oct 15, 2024); Verastem, Inc. (Member, Audit Committee; Member, Compensation Committee; Member, Commercialization Committee · Since at least Oct 20, 2022); Geron Corporation (EVP, Corp Strategy & CCO · Dec 2, 2019 – Jun 10, 2024 · Past) | Chief Commercial Officer · Feb 6, 2018 – Jul 12, 2019 · Past |
| June Almenoff Other companies: Tenax Therapeutics, Inc. (Director · Since at least Dec 10, 2024); Avalo Therapeutics, Inc. (Director · Since at least Dec 20, 2023) | Director · Since at least Nov 1, 2024 |
| C. David Nicholson Other companies: Adverum Biotechnologies Inc (Director · Since at least Nov 3, 2023) | Director · Since at least Dec 28, 2023 |
| Dragan Cicic Other companies: SELLAS Life Sciences Group, Inc. (Senior Vice President, Chief Development Officer · Since at least Jun 20, 2024) | Chief Technology Officer · Dec 28, 2012 – Mar 14, 2017 · Past |
| Kaushik J Dave Other companies: Antares Pharma Inc (Executive Vice President · May 6, 2013 – Jun 3, 2013 · Past) | CEO and Interim CFO, Director · Sep 16, 2013 – Mar 14, 2017 · Past |
| Mark Stanley Berger Other companies: Genprex, Inc. (Chief Medical Officer · Since at least Sep 27, 2021) | Chief Medical Officer · Mar 16, 2017 – Sep 1, 2021 · Past |
| Nitya G Ray Other companies: CytoDyn Inc. (Chief Technology Officer · Dec 22, 2018 – Nov 15, 2022 · Past) | Executive VP · Jun 15, 2017 – Jul 13, 2018 · Past |
| Sandesh Seth Other companies: Relmada Therapeutics, Inc. (Director · Jan 6, 2015 – Dec 15, 2015 · Past) | Chief Executive Officer and Chairman of the Board · Since at least Dec 28, 2012 |
| Sergio Traversa Other companies: Relmada Therapeutics, Inc. (Chief Executive Officer · Since at least Jan 6, 2015) | Director · Dec 28, 2012 – Mar 14, 2017 · Past |
| Steve O'Loughlin Other companies: CNS Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Mar 2, 2026) | Chief Financial Officer · Sep 1, 2021 – Mar 31, 2025 · Past |
| Adeela Kamal | Chief Scientific Officer · Since at least Sep 3, 2026 |
| Ajit Shetty | Director · Since at least Mar 28, 2017 |
| Dale L Ludwig | Chief Science & Tech. Officer · Jan 8, 2018 – Aug 12, 2020 · Past |
| Diane S Button | President/Secretary/Treasurer, Director · Feb 7, 2007 – Feb 7, 2007 · Past |
| Enza Guagenti | Chief Financial Officer · Dec 28, 2012 – Dec 28, 2012 · Past |
| Gary Siegel | Vice President, Controller · Since at least Nov 5, 2026 |
| Jeffrey W. Chell | Director · Since at least Apr 27, 2018 |
| John V Talley | CEO and President, Director · Dec 28, 2012 – Dec 28, 2012 · Past |
| Julie Gibson | Vice President, Portfolio and Clinical Operations · Since at least Nov 5, 2026 |
| Matt David | Chief Financial Officer · Since at least Oct 15, 2026 |
| Matthew T David | Chief Financial Officer · Since at least Oct 14, 2026 |
| Monideepa Roy | Senior Vice President, Corporate Development – R&D · Since at least Apr 22, 2026 |
| Paul Diamond | Vice President, Legal and Intellectual Property Counsel · Since at least Nov 5, 2026 |
| Richard l. Steinhart | Director · Since at least Sep 4, 2026 |
| Ryan Chu | Vice President, Finance and Investor Relations · Since at least Nov 5, 2026 |
| Sean Maenpaa | Senior Vice President, Business Development · Since Oct 12, 2026 |
| Steffen Heeger | Chief Medical Officer · Since at least Jun 1, 2026 |